{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:42:04Z","timestamp":1791996124857,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Mount Sinai Hospital","award":["Joan Murphy Research Award Funding"],"award-info":[{"award-number":["Joan Murphy Research Award Funding"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1136\/ijgc-2023-004526","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T23:14:42Z","timestamp":1695078882000},"page":"1724-1732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gestational trophoblastic neoplasia: does centralization of care impact clinical management?"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5499-240X","authenticated-orcid":false,"given":"Cristina","family":"Mitric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-1245","authenticated-orcid":false,"given":"Stephanie","family":"Lheureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Laframboise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004526_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143 Suppl 2","author":"Ngan","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004526_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jogc.2020.03.001","article-title":"Guideline no. 408: management of gestational trophoblastic diseases","volume":"43","author":"Eiriksson","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1136\/ijgc-2023-004526_bb0020","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.6004\/jnccn.2019.0053","article-title":"Gestational trophoblastic neoplasia, version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Abu-Rustum","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1136\/ijgc-2023-004526_bb0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2015.05.041","article-title":"Fatal gestational trophoblastic neoplasia: an analysis of treatment failures at the brewer trophoblastic disease center from 1979-2012 compared to 1962-1978","volume":"138","author":"Neubauer","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0030","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/IGC.0000000000000294","article-title":"Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer Intergroup","volume":"24","author":"Mangili","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004526_bb0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2020.02.011","article-title":"Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease","volume":"130","author":"Lok","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-004526_bb0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajog.2006.10.867","article-title":"First epidemiological data from the French Trophoblastic Disease Reference Center","volume":"196","author":"Golfier","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004526_bb0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.11.014","article-title":"Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study","volume":"140","author":"Eysbouts","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-004526_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155 Suppl 1","author":"Ngan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004526_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","article-title":"Gestational trophoblastic neoplasia, FIGO 2000 staging and classification","volume":"83 Suppl 1","author":"Ngan","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004526_bb0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ygyno.2020.05.013","article-title":"An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG\/GOG 275","volume":"158","author":"Schink","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0070","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"2016","author":"Lawrie","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2023-004526_bb0075","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2012.03.003","article-title":"Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia","volume":"125","author":"Lybol","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0080","first-page":"7","article-title":"Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010","volume":"59","author":"Agarwal","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2023-004526_bb0085","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/ijgc-2020-001237","article-title":"Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America","volume":"30","author":"Maest\u00e1","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004526_bb0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/ijgc-2018-000028","article-title":"Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?","volume":"29","author":"Frijstein","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004526_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jcms.2021.01.030","article-title":"Head and neck Ewing sarcoma: French surgical practice analysis pleads for surgery centralization","volume":"50","author":"Bouaoud","year":"2022","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1136\/ijgc-2023-004526_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejso.2017.12.012","article-title":"Centers of excellence or excellence networks: the surgical challenge and quality issues in rare cancers","volume":"45","author":"Sandrucci","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0105","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24 Suppl 6","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2021-003312","article-title":"Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry","author":"Schoenen","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004526_bb0115","first-page":"195","article-title":"Evolution of a specialist gestational trophoblastic disease service with a major nursing component: the Sheffield, United Kingdom, experience","volume":"59","author":"Ireson","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2023-004526_bb0120","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1470-2045(17)30686-1","article-title":"Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach","volume":"19","author":"Ireson","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0125","unstructured":"Dana-Farber Cancer Institute . Gestational trophoblastic disease (GTD). n.d.Available: https:\/\/www.dana-farber.org\/gestational-trophoblastic-disease\/"},{"key":"10.1136\/ijgc-2023-004526_bb0130","first-page":"187","article-title":"Timing of referral to the New England Trophoblastic Disease Center: does referral with molar pregnancy versus postmolar gestational trophoblastic neoplasia affect outcomes?","volume":"61","author":"Diver","year":"2016","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2023-004526_bb0135","author":"Northwestern Medicine, Feinberg School of Medicine","year":"2022","journal-title":"John I. Brewer Trophoblastic Disease Center"},{"issue":"2 Pt 1","key":"10.1136\/ijgc-2023-004526_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","article-title":"Gestational trophoblastic neoplasia: treatment outcomes","volume":"112","author":"Hoekstra","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004526_bb0145","author":"Anon","year":"2022","journal-title":"Charing Cross Gestational Trophoblast Disease Service"},{"key":"10.1136\/ijgc-2023-004526_bb0150","author":"Anon","year":"2022","journal-title":"Sheffield Trophoblastic Disease Centre"},{"key":"10.1136\/ijgc-2023-004526_bb0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2022.03.039","article-title":"Experience of women on the Irish National Gestational Trophoblastic Disease Registry","volume":"272","author":"Joyce","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1136\/ijgc-2023-004526_bb0160","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2021.20406","article-title":"Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre","volume":"151","author":"Fehlmann","year":"2021","journal-title":"Swiss Med Wkly"},{"key":"10.1136\/ijgc-2023-004526_bb0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2020.04.704","article-title":"Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study","volume":"158","author":"Freitas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004526_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277892","article-title":"Neutrophil\/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia","volume":"17","author":"Braga","year":"2022","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2023-004526_bb0175","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/IGC.0000000000000401","article-title":"Quebec Trophoblastic Disease Registry: how to make an easy-to-use dynamic database","volume":"25","author":"Sauthier","year":"2015","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24017730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:41:03Z","timestamp":1753224063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24017730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1048891X24017730"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004526","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational trophoblastic neoplasia: does centralization of care impact clinical management?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}